Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Stroke. 2021 Mar 8;52(5):1733–1740. doi: 10.1161/STROKEAHA.120.032888

Table 1.

Baseline characteristics of included and excluded patients

Covariate Missing IL-6 Level (n = 267) With IL-6 Level (n = 552) p
Age, year, mean [SD] 66 [13] 64 [13] 0.05
Female, No. (%) 106 (40) 202 (37) 0.39
Hypertension, No. (%) 219 (93) 467 (93) 0.91
Hyperlipidemia, No. (%) 72 (31) 153 (31) 0.89
Diabetes, No. (%) 31 (13) 60 (12) 0.74
Atrial Fibrillation, No. (%) 10 (4) 19 (4) 0.87
Coronary Artery Disease, No. (%) 14 (6) 28 (6) 0.91
COPD, No. (%) 4 (2) 16 (3) 0.44
ICH Location, No. (%) 0.92
 Non-lobar 202 (81) 433 (81)
 Lobar 35 (14) 78 (15)
ICH Volume, mL, mean [SD] 22 [25] 23 [26] 0.65
PHE Volume, mL, mean [SD] 16 [18] 18 [22] 0.18
Presence of IVH, n (%) 97 (36) 205 (37) 0.86
Treatment Group, No. (%) 0.74
20 ug 90 (34) 172 (31)
80 ug 81 (30) 183 (33)
Placebo 96 (36) 197 (36)
Poor Outcome (mRS 4–6), No. (%) 128 (48) 262 (48) 0.91

Abbreviations: SD = standard deviation, COPD = chronic obstructive pulmonary disease, ICH = intracerebral hemorrhage, PHE = perihematomal edema, IVH = intraventricular hemorrhage, mRS = modified Rankin Scale